Louisbourg Investments »

Intellia Therapeutics shares owned by Louisbourg Investments

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Louisbourg Investments from 13F filings

Historical chart of Louisbourg Investments investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Louisbourg Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Louisbourg Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8k 200 8.99

More positions owned by Louisbourg Investments

Canadian Natl Ry (CNI)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
iShares S&P 500 Index (IVV)
Wheaton Precious Metals Corp (WPM)
Shopify Inc cl a (SHOP)
Taiwan Semiconductor Mfg (TSM)
Rogers Communications -cl B (RCI)
Gildan Activewear Inc Com Cad (GIL)
Pembina Pipeline Corp (PBA)
Vanguard S&p 500 Etf idx (VOO)
salesforce (CRM)
Amazon (AMZN)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Lightspeed Comme (LSPD)

View all positions for Louisbourg Investments

Top funds holding Intellia Therapeutics

Vanguard Group
ARK Investment Management
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Nikko Asset Management Americas
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Two Sigma Advisers
FMR

View all funds holding Intellia Therapeutics